Position in PFE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,125,667
-$199,737 QoQ
Shares Held
46,747
-1.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#1,261
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Lantz Financial LLC holds $16,892,877 across 12 Drug Manufacturers - General names. PFE ranks #7 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
12,860 | $3,266,054 | |
| 2 | LLY |
ELI LILLY & Co
|
2,003 | $2,402,458 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,221 | $2,212,898 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
16,595 | $2,096,612 | |
| 5 | ABBV |
AbbVie Inc.
|
8,202 | $2,063,951 | |
| 6 | NVS |
Novartis AG
|
7,596 | $1,190,445 | |
| 7 | PFE |
Pfizer Inc
This page
|
46,747 | $1,125,667 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,833 | $739,437 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,125,667 | 46,747 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,325,404 | 47,201 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $1,154,911 | 46,382 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,154,855 | 45,324 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $855,235 | 35,282 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $827,629 | 32,661 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $837,392 | 31,564 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $914,388 | 31,596 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $817,939 | 29,233 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $848,650 | 30,582 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $869,486 | 30,201 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $996,095 | 30,030 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $1,058,768 | 28,865 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $1,229,956 | 30,146 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $1,388,911 | 27,106 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $1,116,098 | 25,505 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,329,257 | 25,353 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $1,363,311 | 26,334 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $3,454,661 | 58,504 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $2,532,127 | 58,873 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $2,355,630 | 60,154 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $2,112,897 | 58,319 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $2,095,225 | 56,920 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $2,164,490 | 58,978 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $1,883,816 | 57,609 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $2,017,247 | 61,803 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||